e.g. mhealth
Search Results (1 to 10 of 54 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 16 Journal of Medical Internet Research
- 15 JMIR Research Protocols
- 8 JMIR Formative Research
- 5 JMIR Public Health and Surveillance
- 4 JMIR mHealth and uHealth
- 2 JMIR Dermatology
- 1 JMIR AI
- 1 JMIR Cancer
- 1 JMIR Infodemiology
- 1 JMIR Pediatrics and Parenting
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Evaluating Perceptions of the CANreduce 2.0 eHealth Intervention for Cannabis Use: Focus Group Study
Cannabis is the most widely used drug worldwide, posing a significant problem due to its negative effects on users’ well-being and its broader impact on public health. According to the latest report from the United Nations Office on Drugs and Crime [1], approximately 228 million people consumed cannabis in 2022, with many countries reporting a sustained increase in the prevalence of cannabis use (CU), hospitalizations, and diagnosed psychiatric disorders related to CU.
J Med Internet Res 2025;27:e65025
Download Citation: END BibTex RIS
Finally, it is crucial to acknowledge that the potential impact of polysubstance use on the interpretation of physiological signals associated with self-reported cannabis intoxication was not included. While ESM is used to collect information on the use of other substances, our analysis did not account for the effects of polysubstance use due to the limited scope of the study. The presence of polysubstance use could potentially confound the physiological signals attributed to marijuana.
JMIR AI 2025;4:e52270
Download Citation: END BibTex RIS
However, the prevalence of cannabis use in Thailand increased from 2.2% in 2019 to 4.2% by 2021, following the legalization of cannabis for recreational use [14]. A study conducted in Northern Thailand showed that 40% of women with breast cancer had requested the use of medical cannabis from their physician, indicating an increasing interest in medical cannabis [15].
Moreover, a law was passed in 2019 which allowed the use of cannabis for medical purposes [14,16].
JMIR Cancer 2024;10:e55300
Download Citation: END BibTex RIS
Since 1996, states across the United States have legalized cannabis for medical use [1]. The legalization of cannabis or medical marijuana (MMJ) adds another layer of complexity to comprehensive patient care, as treatment with MMJ is managed outside of traditional health care management and documentation systems [2]. In Pennsylvania, MMJ is not currently “prescribed”—rather, a physician with appropriate privileges must certify that a given patient has 1 of 24 serious medical conditions [3,4].
JMIR Form Res 2024;8:e65957
Download Citation: END BibTex RIS
Discussions of Cannabis Over Patient Portal Secure Messaging: Content Analysis
For patient messages, five primary content categories were coded: (1) correctly classified message (ie, the keyword which flagged the message as pertaining to a plant-based product), (2) message author (patient or nonpatient), (3) time of cannabis use, (4) reason for cannabis use, and (5) purpose of cannabis mention in message. “Time of cannabis” use codes were mutually exclusive. An exception was made if a message described the use of multiple different cannabis products.
J Med Internet Res 2024;26:e63311
Download Citation: END BibTex RIS
Conversely, rates of daily cannabis use (20+ use occasions in the past 30 days) are at all-time highs, with 11% of young adults reporting daily use [1]. Pacing with increases in cannabis use in recent years, young adults are also increasingly reporting co-use of alcohol and cannabis use, with approximately one-quarter reporting past-year simultaneous use or use of both substances so that the effects overlap [2].
JMIR Form Res 2024;8:e60193
Download Citation: END BibTex RIS
Each data entry was assigned one of 5 drug categories: opiates, cannabis, amphetamines, cocaine, or others. Within each data extract, we calculated the total sum of grams for all drugs and each category of interest (opiates, cannabis, and all drugs excluding cannabis) per region. These sums were then adjusted by dividing them by the population size of the respective regions.
JMIR Form Res 2024;8:e56006
Download Citation: END BibTex RIS
The prevalence of cannabis consumption and clinical diagnoses of cannabis use disorder (CUD) has increased in the past 2 decades [1-3]. The intensification in delta-9-tetrahydrocannabinol potency of cannabis products in recent years, expanding types of consumption modalities of high-potency products (eg, vaping, dabs, and edibles), and increased perceived acceptability of cannabis use increase the risk for greater use and dependence on cannabis [4-12].
J Med Internet Res 2024;26:e47357
Download Citation: END BibTex RIS
Alcohol and cannabis use are among the most commonly used substances in the United States. Rates of using both substances are particularly high among young adults [1], who also report the highest rates of simultaneous alcohol and cannabis use (ie, using alcohol and cannabis at the same time so that the effects overlap) [2]. Young adults (ie, aged 18-26 years) are the only age group for whom rates of cannabis use increased following the legalization of cannabis [3].
JMIR Res Protoc 2024;13:e58685
Download Citation: END BibTex RIS
However, it is important to note that dual cannabis and tobacco use, or co-use, can manifest in various patterns such as (1) concurrent use, where both substances are consumed simultaneously in the form of joints, which is the most prevalent form of cannabis use in Europe [3,5,6]; (2) sequential concurrent use, involving the use of cannabis followed by tobacco or vice versa; (3) asynchronous concurrent use, characterized by cannabis and tobacco usage within the past month but not necessarily during the same
JMIR Res Protoc 2024;13:e58335
Download Citation: END BibTex RIS